logo
#

Latest news with #CanaccordGenuity

Why BlackSky Technology Stock Popped Today
Why BlackSky Technology Stock Popped Today

Yahoo

time13 hours ago

  • Business
  • Yahoo

Why BlackSky Technology Stock Popped Today

BlackSky won a $24 million delivery order from NGA earlier in the week. This morning, Canaccord Genuity raised its price target on BlackSky stock. BlackSky's revenue growth remains slow, and the stock remains unprofitable. 10 stocks we like better than BlackSky Technology › Shares of BlackSky Technology (NYSE: BKSY), one of the leading providers of digital satellite photos of Earth from space, rocketed 18.9% through 12:35 p.m. ET Thursday on a couple of positive developments. On Tuesday, BlackSky announced the National Geospatial-Intelligence Agency (NGA) awarded the company a $24 million, four-year contract to perform global monitoring of military and economic facilities. Two days later -- today -- Canaccord Genuity analyst Austin Moeller responded by raising his price target on BlackSky stock from $14 to $20 per share. Let's start with the NGA contract. Technically a "delivery order" under a much larger umbrella contract awarded last year, this "Luno A Facility Operational Monitoring" contract hires BlackSky to "perform AI-enabled object and pattern-of-life change detection to monitor trends and anomalies in vehicle, aircraft, vessel, railcar, and ground equipment activity at military and economic facilities worldwide, including ports, airfields, military installations, and railways." So it's basically it's a spy satellite contract. It's also worth an additional $6 million a year to BlackSky, with the potential to grow even bigger over time, as more delivery orders under the original umbrella contract roll in. But is this development big enough to justify adding more than $100 million to BlackSky's market capitalization today? I doubt it. BlackSky stock has already more than doubled over the past year. Yet revenues are up less than 10%, the company's still burning cash, and it's still losing about $54 million a year. Analysts polled by S&P Global Market Intelligence don't expect BlackSky to earn its first profit before 2028 at the earliest. While $20 a share may not sound like much today, I'm afraid BlackSky stock is still too expensive to buy. Before you buy stock in BlackSky Technology, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and BlackSky Technology wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,731!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $945,846!* Now, it's worth noting Stock Advisor's total average return is 818% — a market-crushing outperformance compared to 175% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why BlackSky Technology Stock Popped Today was originally published by The Motley Fool

Stock Movers: Nike, Uber, United Natural Foods
Stock Movers: Nike, Uber, United Natural Foods

Bloomberg

timea day ago

  • Business
  • Bloomberg

Stock Movers: Nike, Uber, United Natural Foods

On this episode of Stock Movers: - Nike (NKE) shares rise after the sneaker company's said its yearlong sales decline is finally starting to ease, suggesting that CEO Elliott Hill's strategic moves are paying off. - Uber (UBER) and Lyft (LYFT) shares fall after both rideshare firms were downgraded to hold from buy at Canaccord Genuity as analyst George Gianarikas sees 'potential for rapid disruption.' - United Natural Foods (UNFI) is climbing after the food distributor said a previously disclosed cybersecurity incident has been contained, and it's now regularly receiving and shipping products to retailers across its network.

5 Must-Read Analyst Questions From EverQuote's Q1 Earnings Call
5 Must-Read Analyst Questions From EverQuote's Q1 Earnings Call

Yahoo

timea day ago

  • Business
  • Yahoo

5 Must-Read Analyst Questions From EverQuote's Q1 Earnings Call

EverQuote's first quarter results were met with a significant negative market reaction, despite revenue and profits exceeding Wall Street expectations. Management attributed the quarter's performance to strong enterprise carrier spending and ongoing investments in AI-powered traffic management, which CEO Jayme Mendal said has enabled the company to 'leverage a data advantage through the use of AI throughout our traffic and distribution systems.' The company also noted that its agency operations and core auto insurance vertical saw substantial growth, supported by improved referral quality and the rollout of Smart Campaigns for carriers. Is now the time to buy EVER? Find out in our full research report (it's free). Revenue: $166.6 million vs analyst estimates of $158.3 million (83% year-on-year growth, 5.2% beat) Adjusted EBITDA: $22.51 million vs analyst estimates of $19.97 million (13.5% margin, 12.7% beat) Revenue Guidance for Q2 CY2025 is $157.5 million at the midpoint, above analyst estimates of $149.5 million EBITDA guidance for Q2 CY2025 is $21 million at the midpoint, above analyst estimates of $18.59 million Operating Margin: 4.8%, up from 1.9% in the same quarter last year Market Capitalization: $858 million While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Maria Ripps (Canaccord Genuity) asked about the potential impact of auto tariffs in the second half of the year; CEO Jayme Mendal and CFO Joseph Sanborn responded that carrier profitability remains strong enough to absorb higher claims costs if tariffs take effect, with no significant change to growth expectations at this time. Jason Kreyer (Craig Hallum) questioned the timing and impact of AI and machine learning on variable marketing margin (VMM); Mendal explained that benefits are being realized through improved traffic bidding and operational efficiency, but more impact is anticipated as tool adoption grows. Zach Cummins (B. Riley) inquired about the health and expansion of the agent channel; Mendal highlighted deeper agent relationships, new value-added products, and a strategy to build a 'one-stop growth shop' for agents as key growth levers. Ralph Schackart (William Blair) asked about adoption and results of the Smart Campaigns product; Mendal shared that customer performance improved by over 40% in some cases and that broader adoption is beginning to impact overall platform performance. Mayank Tandon (Needham) explored the headroom for budget growth among top customers and capital allocation priorities; Mendal noted that growth is limited more by operational execution than budget constraints, while Sanborn outlined a focus on organic technology investment, selective M&A, and a potential share buyback. In the coming quarters, the StockStory team will closely monitor (1) the pace of AI-driven product adoption and its measurable impact on carrier and agent performance, (2) EverQuote's ability to maintain margin expansion while increasing technology and data investments, and (3) developments in the auto insurance market, including macroeconomic volatility and potential effects from auto parts tariffs. The evolution of the agency channel and success in home and renters insurance verticals will also be key signposts. EverQuote currently trades at $23.89, down from $26.36 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

VIZSLA SILVER CLOSES US$100M BOUGHT DEAL OFFERING
VIZSLA SILVER CLOSES US$100M BOUGHT DEAL OFFERING

Cision Canada

time2 days ago

  • Business
  • Cision Canada

VIZSLA SILVER CLOSES US$100M BOUGHT DEAL OFFERING

VANCOUVER, BC, June 26, 2025 /CNW/ - Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company") is pleased to announce that it has completed its previously announced bought deal public offering of 33,334,000 common shares of the Company (the " Common Shares") at a price of US$3.00 per Common Share (the " Offering Price") for aggregate gross proceeds of US$100,002,000 (the " Offering"). The Offering was led by Canaccord Genuity, as sole bookrunner and lead underwriter, on behalf of a syndicate of underwriters that included CIBC Capital Markets, National Bank Financial Inc., Ventum Financial Corp., BMO Capital Markets and Raymond James Ltd. (collectively, the " Underwriters"). The Company has granted the Underwriters an over-allotment option, exercisable at the Offering Price for a period of 30 days after and including the closing date of the Offering, to purchase up to an additional 5,000,100 Common Shares. The Common Shares were offered pursuant to a final prospectus supplement of the Company dated June 23, 2025 (the " Prospectus Supplement") to the short form base shelf prospectus of the Company dated April 28, 2025 (the " Base Shelf Prospectus"), in all of the provinces of Canada, except Quebec, and in the United States pursuant to a prospectus supplement dated June 23, 2025 (the " US Prospectus Supplement") filed as part of an effective registration statement on Form F-10 filed under the Canada/U.S. multi-jurisdictional disclosure system. The Offering remains subject to the final approval of the Toronto Stock Exchange (the " TSX"). The net proceeds of the Offering are expected to be used to advance the exploration and development of the Panuco Project, exploration of the Santa Fe Project, potential future acquisitions, as well as for working capital and general corporate purposes as set out in the Prospectus Supplement. Copies of the applicable offering documents can be obtained free of charge under the Company's profile on SEDAR+ at and EDGAR at Delivery of the Base Shelf Prospectus and the Prospectus Supplement and any amendments thereto will be satisfied in accordance with the "access equals delivery" provisions of applicable Canadian securities legislation. An electronic or paper copy of the Prospectus Supplement, the US Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement may be obtained, without charge, from Canaccord Genuity by phone at 416-869-3052 or by e-mail at [email protected] by providing Canaccord Genuity with an email address or address, as applicable. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. About Vizsla Silver Vizsla Silver is a Canadian mineral exploration and development company headquartered in Vancouver, BC, focused on advancing its flagship, 100%-owned Panuco silver-gold project located in Sinaloa, Mexico. The Company recently completed a Preliminary Economic Study for Panuco in July 2024 which highlights 15.2 Moz AgEq of annual production over an initial 10.6-year mine life, an after-tax NPV5% of US$1.1B, 86% IRR and a 9-month payback at US$26/oz Ag and US$1,975/oz Au. Vizsla Silver aims to become the world's leading silver company by implementing a dual track development approach at Panuco, advancing mine development, while continuing district scale exploration through low-cost means. This news release includes certain "Forward Looking Statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward looking information" under applicable Canadian securities laws, including those relating to information contained in the Preliminary Economic Study (including annual production, mine life, NPV, IRR and payback) and also regarding the terms of the Offering and the expected use of proceeds thereof, which ultimately remains the subject of the Company's discretion, and final approval of the TSX. When used in this news release, the words "anticipate", "believe", "estimate", "expect", "target", "plan", "forecast", "may", "would", "could", "schedule" and similar words or expressions, identify forward looking statements or information. Forward looking statements and forward looking information are based on management's reasonable assumptions, estimates, expectations, analyses and opinions, which are based on management's experience and perception of trends, current conditions and expected developments, and other factors that management believes are relevant and reasonable in the circumstances, but which may prove to be incorrect. Assumptions have been made regarding, among other things, the price of silver, gold, and other metals; costs of exploration and development; the estimated costs of development of exploration projects; Vizsla Silver's ability to operate in a safe and effective manner and its ability to obtain financing on reasonable terms. These statements reflect Vizsla Silver's respective current views with respect to future events and are necessarily based upon a number of other assumptions and estimates that, while considered reasonable by management, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance, or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward looking statements or forward-looking information and Vizsla Silver has made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation: the Company's dependence on one mineral project; precious metals price volatility; risks associated with the conduct of the Company's mining activities in Mexico; regulatory, consent or permitting delays; risks relating to reliance on the Company's management team and outside contractors; risks regarding mineral resources and reserves; the Company's inability to obtain insurance to cover all risks, on a commercially reasonable basis or at all; currency fluctuations; risks regarding the failure to generate sufficient cash flow from operations; risks relating to project financing and equity issuances; risks and unknowns inherent in all mining projects, including the inaccuracy of reserves and resources, metallurgical recoveries and capital and operating costs of such projects; contests over title to properties, particularly title to undeveloped properties; laws and regulations governing the environment, health and safety; operating or technical difficulties in connection with mining or development activities; employee relations, labour unrest or unavailability; the Company's interactions with surrounding communities and artisanal miners; the Company's ability to successfully integrate acquired assets; the speculative nature of exploration and development, including the risks of diminishing quantities or grades of reserves; stock market volatility; conflicts of interest among certain directors and officers; lack of liquidity for shareholders of the Company; litigation risk; and the factors identified under the caption "Risk Factors" in the Prospectus Supplement, the US Prospectus Supplement and Vizsla Silver's management discussion and analysis. Readers are cautioned against attributing undue certainty to forward looking statements or forward-looking information. Although Vizsla Silver has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be anticipated, estimated or intended. Vizsla Silver does not intend, and does not assume any obligation, to update these forward looking statements or forward-looking information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements or information, other than as required by applicable law. SOURCE Vizsla Silver Corp.

Canaccord Genuity Maintains a Buy on Inventiva (IVA) With a $20 Price Target
Canaccord Genuity Maintains a Buy on Inventiva (IVA) With a $20 Price Target

Yahoo

time2 days ago

  • Business
  • Yahoo

Canaccord Genuity Maintains a Buy on Inventiva (IVA) With a $20 Price Target

Inventiva S.A. (NASDAQ:IVA) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. Analyst Edward Nash from Canaccord Genuity maintained a Buy rating on Inventiva S.A. (NASDAQ:IVA) on June 5, keeping the price target at $20.00. The rating was based on several factors, including the potential of lanifibranor, the company's lead asset in the MASH space. Lanifibranor's oral administration and direct anti-fibrotic effects distinguish it from other treatments in development, with a primary focus on liver fat reduction. A research scientist in an idiopathic pulmonary fibrosis laboratory, carrying out clinical trials. The analyst also reasoned that Lanifibranor can be used in conjunction with other treatments, including GLP-1s and SGLT2 inhibitors. This factor is a significant boost to its appeal, especially when considering the high prevalence of type 2 diabetes in MASH patients. Nash stated that the drug is progressing well, which can be corroborated by the completion of full enrollment in the Phase III NATiV3 trial and the anticipated top-line data in H2 2026. Major pharmaceutical companies are also showing increasing interest in the MASH space, further supporting the optimistic outlook for Inventiva S.A. (NASDAQ:IVA). Inventiva S.A. (NASDAQ:IVA) is a clinical-stage biopharmaceutical company that develops oral small-molecule therapies to treat non-alcoholic steatohepatitis or NASH. It also develops therapies for other diseases with considerable unmet medical needs. While we acknowledge the potential of IVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store